Estimating the Prevalence of a True Oligometastatic Disease

Petr Szturz; Pierluigi Bonomo; Jan B. Vermorken

doi:10.3390/cancers15010214

Cancers (Dec 2022)

Estimating the Prevalence of a True Oligometastatic Disease

Petr Szturz,
Pierluigi Bonomo,
Jan B. Vermorken

Affiliations

Petr Szturz: Medical Oncology, Department of Oncology, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland
Pierluigi Bonomo: Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy
Jan B. Vermorken: Department of Medical Oncology, Antwerp University Hospital, 2650 Edegem, Belgium

DOI: https://doi.org/10.3390/cancers15010214
Journal volume & issue: Vol. 15, no. 1
p. 214

Abstract

Read online

To delineate a patient group with few distant metastases that could possibly benefit from a curative therapeutic strategy employing a local approach, the term oligometastatic disease (OMD) was introduced into the clinical practice almost 30 years ago [...]

n/a

Published in Cancers

ISSN: 2072-6694 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.mdpi.com/journal/cancers/

About the journal

Abstract

Keywords